Advanced chronic lung disease: Need for an active interdisciplinary approach

Swiss Medical Weekly

Volumn 137, Issue 43-44, 2007, Pages 593-601

  Hofer, Markus ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Advanced lung diseases; Co morbidities; Cystic fibrosis; Lung transplantation; Multidisciplinary team; Pulmonary fibrosis

Indexed keywords

CHRONIC LUNG DISEASE; COMORBIDITY; HUMAN; INTENSIVE CARE UNIT; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; PATIENT REFERRAL; SHORT SURVEY; SURVIVAL; TERTIARY HEALTH CARE;

EID: 36148988419     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (34)

1. Freeman D, Price D. ABC of chronic obstructive pulmonary disease. Primary care and palliative care. BMJ. 2006;333(7560):188-90.
2. Simonds AK. Ethics and decision making in end stage lung disease. Thorax. 2003;58(3):272-7.
3. Minai OA, Maurer JR, Kesten S. Comorbidities in end-stage lung disease. J Heart Lung Transplant. 1999;18(9):891-903.
4. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114-21.
5. Wilkinson TM, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest. 2006;129(2):317-24.
6. van Ewijk BE, van der Zalm MM, Wolfs TF, van der Ent CK. Viral respiratory infections in cystic fibrosis. J Cyst Fibros. 2005;4(Suppl 2):31-6.
7. Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest. 2006;129(6):1653-72.
8. Chung MJ, Goo JM, Im JG. Pulmonary tuberculosis in patients with idiopathic pulmonary fibrosis. Eur J Radiol. 2004;52(2):175-9.
9. Ader F, Nseir S, Le Berre R, Leroy S, Tillie-Leblond I, Marquette CH, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect. 2005;11(6):427-9.
10. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax. 1980;35(7):496-9.
11. Pezzetta E, Fitting JW, Ris HB. Advances in thoracic surgery: emphysema and simultaneous bronchial carcinoma. Swiss Med Wkly. 2003;133(1-2):4-8.
12. Budev MM, Arroliga AC, Wiedemann HP, Matthay RA. Cor pulmonale: an overview. Semin Respir Crit Care Med. 2003;24(3):233-44.
13. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129(3):746-52.
14. Fraser KL, Tullis DE, Sasson Z, Hyland RH, Thornley KS, Hanly PJ. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest. 1999;115(5):1321-8.
15. Tillie-Leblond I, Marquette CH, Perez T, Scherpereel A, Zanetti C, Tonnel AB, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med. 2006;144(6):390-6.
16. Reed A, Snell GI, McLean C, Williams TJ. Outcomes of patients with interstitial lung disease referred for lung transplant assessment. Intern Med J. 2006;36(7):423-30.
17. Sahn SA, Heffher JE. Spontaneous pneumothorax. N Engl J Med. 2000;342(12):868-74.
18. Tschopp JM, Rami-Porta R, Noppen M, Astoul P. Management of spontaneous pneumothorax: state of the art. Eur Respir J. 2006;28(3):637-50.
19. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128(4):2640-6.
20. Van der Woude BT, Kropmans TJ, Douma KW, Van der Bij W, Ouwens JP, Koeter GH, et al. Peripheral muscle force and exercise capacity in lung transplant candidates. Int J Rehabil Res. 2002;25(4):351-5.
21. Frauman AG. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev. 1996;15(4):203-6.
22. Tschopp O, Boehler A, Speich R, Weder W, Seifert B, Russi EW, et al. Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant. 2002;2(2):167-72.
23. Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Thorax. 2002;57(1):29-33.
24. Ai-Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest. 2005;128(2):518-24.
25. Rivera-Fernandez R, Navarrete-Navarro P, Fernandez-Mondejar E, Rodriguez-Elvira M, Guerrero-Lopez F, Vazquez-Mata G. Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med. 2006;34(9):2317-24.
26. Saydain G, Islam A, Afessa B, Ryu JH, Scott JP, Peters SG. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med. 2002;166(6):839-42.
27. Texereau J, Jamal D, Choukroun G, Burgel PR, Diehl JL, Rabbat A, et al. Determinants of mortality for adults with cystic fibrosis admitted in Intensive Care Unit: a multicenter study. Respir Res. 2006;7:14.
28. Speich R, Nicod LP, Aubert JD, Spiliopoulos A, Wellinger J, Robert JH, et al. Ten years of lung transplantation in Switzerland: results of the Swiss Lung Transplant Registry. Swiss Med Wkly. 2004;134(1-2):18-23.
29. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006; 25(7):745-55.
30. Celli BR, Cote CG, Marin JM, Casanova C, Montes dO, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-12.
31. Tutic M, Lardinois D, Imfeld S, Korom S, Boehler A, Speich R, et al. Lung-volume reduction surgery as an alternative or bridging procedure to lung transplantation. Ann Thorac Surg. 2006;82(1):208-13.
32. Mahadeva R, Webb K, Westerbeek RC, Carroll NR, Dodd ME, Bilton D, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998;316(7147):1771-5.
33. Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005;4(1):7-26.
34. Lok SS. Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: a potential advantage to patients. Greater Manchester Lung Fibrosis Consortium. J Heart Lung Transplant. 1999;18(9):884-90.